ferumoxytol · Azurity · NDA 219868
Ferabright
Earliest generic entry, as listed · earliest of 2 marketed strengths
16 Oct 2028
Blocked by exclusivity: NP.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NP | new product | 16 Oct 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 219868 · 001 · RLD | solution, intravenous | EQ 300MG IRON/10ML (EQ 30MG IRON/ML) | 16 Oct 2028 |
| 219868 · 002 · RLD | solution, intravenous | EQ 510MG IRON/17ML (EQ 30MG IRON/ML) | 16 Oct 2028 |